John K Scott Jr. is of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Nov 27, 2023, when has been sold 2,270 shares (Series G Redeemable Preferred Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

John K Scott Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 27 2023
SELL
Other acquisition or disposition
-
2,270 Reduced 100.0%
0 Series G Redeemable Pr...
Jun 29 2023
BUY
Grant, award, or other acquisition
$1,098,000 $0.09 p/Share
12,200,000 Added 27.76%
31,755,832 Common Stock
Jun 05 2023
BUY
Grant, award, or other acquisition
-
11,508,672 Added 37.05%
19,555,832 Common Stock
Jun 01 2023
SELL
Other acquisition or disposition
-
990 Reduced 30.37%
2,270 Series G Redeemable Pr...
Nov 30 2022
BUY
Grant, award, or other acquisition
-
1,250 Added 0.02%
8,109,645 Common Stock
Oct 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,108,395 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,105,895 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,103,395 Common Stock
Jul 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,100,895 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,098,395 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,095,895 Common Stock
Apr 30 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,093,395 Common Stock
Apr 10 2022
BUY
Open market or private purchase
-
3,260 Added 50.0%
3,260 Series G Redeemable Pr...
Mar 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,090,895 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,088,395 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,085,895 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
-
2,500 Added 0.03%
8,083,395 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
-
1,250 Added 0.02%
8,080,895 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
-
32,483 Added 0.4%
8,079,645 Common Stock
JKS

John K Scott Jr.

Dublin, OH

Track Institutional and Insider Activities on NAVB

Follow NAVIDEA BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAVB shares.

Notify only if

Insider Trading

Get notified when an Navidea Biopharmaceuticals, Inc. insider buys or sells NAVB shares.

Notify only if

News

Receive news related to NAVIDEA BIOPHARMACEUTICALS, INC.

Track Activities on NAVB